Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Janus kinase inhibitors in dermatology: Part I. A comprehensive review
Stephanie Chapman, Michael Kwa, Linda Stein Gold, et al.
Journal of the American Academy of Dermatology (2021) Vol. 86, Iss. 2, pp. 406-413
Closed Access | Times Cited: 63

Showing 1-25 of 63 citing articles:

JAK–STAT signaling pathway in the pathogenesis of atopic dermatitis: An updated review
I‐Hsin Huang, Yi‐Teng Hung, Po‐Chien Wu, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 134
Innovation in the treatment of atopic dermatitis: Emerging topical and oral Janus kinase inhibitors
Chisa Nakashima, Shigeto Yanagihara, Atsushi Otsuka
Allergology International (2021) Vol. 71, Iss. 1, pp. 40-46
Open Access | Times Cited: 121
Skin Pigmentation Types, Causes and Treatment—A Review
Amin Mahmood Thawabteh, Alaa Jibreen, Donia Karaman, et al.
Molecules (2023) Vol. 28, Iss. 12, pp. 4839-4839
Open Access | Times Cited: 85
JAK-STAT pathway inhibitors in dermatology
Hélio Amante Miot, Paulo Ricardo Criado, Caio César Silva de Castro, et al.
Anais Brasileiros de Dermatologia (2023) Vol. 98, Iss. 5, pp. 656-677
Open Access | Times Cited: 44
Real-world safety and clinical response of Janus kinase inhibitor upadacitinib in the treatment of hidradenitis suppurativa: A retrospective cohort study
Emily Kozera, Akshay Flora, John W. Frew
Journal of the American Academy of Dermatology (2022) Vol. 87, Iss. 6, pp. 1440-1442
Open Access | Times Cited: 40
Itch and Janus Kinase Inhibitors
Yujin Han, Yu Ri Woo, Sang Hyun Cho, et al.
Acta Dermato Venereologica (2023) Vol. 103, pp. adv00869-adv00869
Open Access | Times Cited: 31
A Comprehensive Review on Skin Pigmentation-Types, Causes, and Treatment
Ameen Mahmood Thawabteh, Alaa Jibreen, Donia Karaman, et al.
(2023)
Open Access | Times Cited: 25
Emerging Oral Therapies for the Treatment of Psoriasis: A Review of Pipeline Agents
Anastasia Drakos, Tiago Torres, Ronald Vender
Pharmaceutics (2024) Vol. 16, Iss. 1, pp. 111-111
Open Access | Times Cited: 10
JAK Inhibitors in Cutaneous T-Cell Lymphoma: Friend or Foe? A Systematic Review of the Published Literature
Seyed Mohammad Vahabi, Saeed Bahramian, Farzad Esmaeili, et al.
Cancers (2024) Vol. 16, Iss. 5, pp. 861-861
Open Access | Times Cited: 9
Management of atopic dermatitis: a narrative review
Michelle Goh, Jenny Sung Won Yun, John Su
The Medical Journal of Australia (2022) Vol. 216, Iss. 11, pp. 587-593
Closed Access | Times Cited: 34
Janus-kinase inhibitors in dermatology: A review of their use in psoriasis, vitiligo, systemic lupus erythematosus, hidradenitis suppurativa, dermatomyositis, lichen planus, lichen planopilaris, sarcoidosis and graft-versus-host disease
Margaret Y. Huang, April W. Armstrong
Indian Journal of Dermatology Venereology and Leprology (2023) Vol. 90, pp. 30-40
Open Access | Times Cited: 16
Pharmacology of inhibitors of Janus kinases – Part 1: Pharmacokinetics
Adina Eichner, Johannes Wohlrab
JDDG Journal der Deutschen Dermatologischen Gesellschaft (2022) Vol. 20, Iss. 11, pp. 1485-1499
Open Access | Times Cited: 23
A case of generalized granuloma annulare treated with upadacitinib
Kristin Slater, Brittany Valk, Francisca Kartono
JAAD Case Reports (2023) Vol. 34, pp. 12-14
Open Access | Times Cited: 13
Serum Lipids Alterations in Patients Under Systemic JAK Inhibitors Treatments in Dermatology: Clinical Aspects and Management
Giovanni Paolino, Mario Valenti, Andrea Carugno, et al.
Medicina (2025) Vol. 61, Iss. 1, pp. 54-54
Open Access
Identifying Research Hotspots and Trends in Psoriasis Literature: Autotuned Topic Modeling with Agent
Sunsi Wu, Dan Wang, Xinpei Gu, et al.
Journal of Investigative Dermatology (2025)
Closed Access
The future of topical JAK inhibitors in the treatment of atopic dermatitis
Joanna Mazgaj, Magdalena Kotewicz, Andrzej Jaworek, et al.
Expert Opinion on Pharmacotherapy (2025)
Closed Access
Mechanism of PPARα agonist in alopecia areata
Xiaomei Xuan, Guoqiang Zhang, Jinfang Zhang, et al.
American Journal of Translational Research (2025) Vol. 17, Iss. 2, pp. 844-855
Closed Access
Update on the Treatment of Chronic Spontaneous Urticaria
Pavel Kolkhir, Jie Shen Fok, Emek Kocatürk, et al.
Drugs (2025)
Open Access
Efficacy and Safety of Tofacitinib in Patients With Refractory Prurigo Nodularis: A 16‐Week, Single‐Center, Prospective, Observational Pilot Study
Ru Dai, Chao-Cheng Chi, Yuchen Lou, et al.
Dermatologic Therapy (2025) Vol. 2025, Iss. 1
Open Access
JAK inhibitors as a promising therapy for immune-mediated photodermatoses
Mohammad Malekan, Saeid Taghiloo, Armaghan Kazeminejad, et al.
Drug Discovery Today (2025), pp. 104344-104344
Closed Access
Off‐Label Use of Topical Ruxolitinib in Dermatology: A Systematic Literature Review and Current Perspectives
Marco Spadafora, Serena Morsia, Vito Di Lernia, et al.
Experimental Dermatology (2025) Vol. 34, Iss. 4
Open Access
TCM and related active compounds in the treatment of gout: the regulation of signaling pathway and urate transporter
Xin Sun, Le Yang, Hui Sun, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 11
Cytokine-pathway blockers worsen mycosis fungoides masquerading as psoriasis.
Gabriela Blanchard, Bettina Bisig, Laurence de Leval, et al.
JAAD Case Reports (2024) Vol. 48, pp. 98-102
Open Access | Times Cited: 4
Biologic and Small Molecule Therapy for Treating Moderate to Severe Atopic Dermatitis: Mechanistic Considerations
Camille Rothenberg‐Lausell, Jonathan Bar, Dante Dahabreh, et al.
Journal of Allergy and Clinical Immunology (2024) Vol. 154, Iss. 1, pp. 20-30
Closed Access | Times Cited: 4
Pharmacodynamics of Janus kinase inhibitors for the treatment of atopic dermatitis
Laura Calabrese, Andrea Chiricozzi, Clara De Simone, et al.
Expert Opinion on Drug Metabolism & Toxicology (2022) Vol. 18, Iss. 5, pp. 347-355
Open Access | Times Cited: 17
Page 1 - Next Page

Scroll to top